← Leaderboards
Hind Lal
Vanderbilt University
$7,028,356
Attributed
$7,673,092
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,539,134 · 6
By mechanism
R01$10,539,134 · 6
Top collaborators
- Carlos J Orihuela2 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- John Peter Wikswo$17,124,536
- Derek J. Williams$5,821,267
- Christopher J. Easley$5,100,785
- Michael L. Freeman$14,431,534
- Jason M Spaeth$2,289,832
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacNovel StrategiesHeartMouse ModelHeart FailureIn VivoBiologyPreventHeart DiseasesPathway InteractionsAdultSignal TransductionMediatingTherapeutic TargetMyocardial DysfunctionVirtualPublic Health RelevanceBasePhenotypeCoronary FibrosisKnockout MicePhosphotransferasesMissionMyocardial
Grant awards (23)
Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease$645,107
R01 · FY2025 · HL · contact PI
Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart$568,474
R01 · FY2025 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$547,513
R01 · FY2025 · HL · contact PI
Novel strategies to mitigate cardiac damage and dysfunction following invasive pneumococcal disease$644,365
R01 · FY2024 · HL · contact PI
Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart$562,534
R01 · FY2024 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$544,035
R01 · FY2024 · HL · contact PI
Project-002$462,111
R01 · FY2022 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$462,111
R01 · FY2022 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$458,029
R01 · FY2021 · HL · contact PI
Project-002$458,029
R01 · FY2021 · HL · contact PI
Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart$371,250
R01 · FY2021 · HL · contact PI
Project-002$428,783
R01 · FY2020 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$428,783
R01 · FY2020 · HL · contact PI
Signaling Mechanisms Governing Myocardial Fibrosis in Diseased Heart$371,250
R01 · FY2020 · HL · contact PI
Novel Mechanisms of Cardiac Function and Dysfunction$425,571
R01 · FY2019 · HL · contact PI
Project-002$425,571
R01 · FY2019 · HL · contact PI
Signaling mechanisms governing myocardial fibrosis in diseased heart$395,000
R01 · FY2019 · HL · contact PI
Signaling mechanisms governing myocardial fibrosis in diseased heart$395,000
R01 · FY2018 · HL · contact PI
Heart Failure in Cancer Patients$395,000
R01 · FY2017 · HL · contact PI
Signaling mechanisms governing myocardial fibrosis in diseased heart$395,000
R01 · FY2017 · HL · contact PI
Heart Failure in Cancer Patients$395,000
R01 · FY2016 · HL · contact PI
Heart Failure in Cancer Patients$386,612
R01 · FY2015 · HL · contact PI
TNNI3K: A cardiac-specific kinase regulating ischemic injury and fibrotic remodel$374,006
R01 · FY2015 · HL · contact PI